These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 35634703)
1. Functionalized lipid-based drug delivery nanosystems for the treatment of human infectious diseases. Almeida Furquim de Camargo B; Fonseca-Santos B; Gonçalves Carvalho S; Corrêa Carvalho G; Delello Di Filippo L; Sousa Araújo VH; Lobato Duarte J; Polli Silvestre AL; Bauab TM; Chorilli M Crit Rev Microbiol; 2023 Mar; 49(2):214-230. PubMed ID: 35634703 [TBL] [Abstract][Full Text] [Related]
2. Nanomedicine as a promising strategy for the theranostics of infectious diseases. Liu H; Zhong W; Zhang X; Lin D; Wu J J Mater Chem B; 2021 Oct; 9(38):7878-7908. PubMed ID: 34611689 [TBL] [Abstract][Full Text] [Related]
3. Highlights in Mesoporous Silica Nanoparticles as a Multifunctional Controlled Drug Delivery Nanoplatform for Infectious Diseases Treatment. Carvalho GC; Sábio RM; de Cássia Ribeiro T; Monteiro AS; Pereira DV; Ribeiro SJL; Chorilli M Pharm Res; 2020 Sep; 37(10):191. PubMed ID: 32895867 [TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for Antimicrobial Agents Delivery-An Up-to-Date Review. Mercan DA; Niculescu AG; Grumezescu AM Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430343 [TBL] [Abstract][Full Text] [Related]
5. Prevention of microbial biofilms - the contribution of micro and nanostructured materials. Grumezescu AM; Chifiriuc CM Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506 [TBL] [Abstract][Full Text] [Related]
6. Topical Drug Delivery of Anti-infectives Employing Lipid-Based Nanocarriers: Dermatokinetics as an Important Tool. Thakur K; Sharma G; Singh B; Katare OP Curr Pharm Des; 2018; 24(43):5108-5128. PubMed ID: 30657036 [TBL] [Abstract][Full Text] [Related]
7. Nanotechnology approaches for global infectious diseases. Kirtane AR; Verma M; Karandikar P; Furin J; Langer R; Traverso G Nat Nanotechnol; 2021 Apr; 16(4):369-384. PubMed ID: 33753915 [TBL] [Abstract][Full Text] [Related]
8. Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. Weiss C; Carriere M; Fusco L; Capua I; Regla-Nava JA; Pasquali M; Scott JA; Vitale F; Unal MA; Mattevi C; Bedognetti D; Merkoçi A; Tasciotti E; Yilmazer A; Gogotsi Y; Stellacci F; Delogu LG ACS Nano; 2020 Jun; 14(6):6383-6406. PubMed ID: 32519842 [TBL] [Abstract][Full Text] [Related]
9. Polymeric therapeutic delivery systems for the treatment of infectious diseases. Aderibigbe BA Ther Deliv; 2017 Jul; 8(7):557-576. PubMed ID: 28633590 [TBL] [Abstract][Full Text] [Related]
10. Application of nanotechnology in drug delivery systems for respiratory diseases (Review). Luo MX; Hua S; Shang QY Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760125 [TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review. Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143 [TBL] [Abstract][Full Text] [Related]
12. Nanotechnological strategies for systemic microbial infections treatment: A review. Dos Santos Ramos MA; Dos Santos KC; da Silva PB; de Toledo LG; Marena GD; Rodero CF; de Camargo BAF; Fortunato GC; Bauab TM; Chorilli M Int J Pharm; 2020 Nov; 589():119780. PubMed ID: 32860856 [TBL] [Abstract][Full Text] [Related]
13. Nanomedicine: novel approaches in human and veterinary therapeutics. Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101 [TBL] [Abstract][Full Text] [Related]
14. Nanosystem functionalization strategies for prostate cancer treatment: a review. de Araújo JTC; Duarte JL; Di Filippo LD; Araújo VHS; Carvalho GC; Chorilli M J Drug Target; 2021 Sep; 29(8):808-821. PubMed ID: 33645369 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases. Rodrigues GR; López-Abarrategui C; de la Serna Gómez I; Dias SC; Otero-González AJ; Franco OL Int J Pharm; 2019 Jan; 555():356-367. PubMed ID: 30453018 [TBL] [Abstract][Full Text] [Related]
16. Recent Trends in Nanotechnology Toward CNS Diseases: Lipid-Based Nanoparticles and Exosomes for Targeted Therapeutic Delivery. Cardoso AM; Guedes JR; Cardoso AL; Morais C; Cunha P; Viegas AT; Costa R; Jurado A; Pedroso de Lima MC Int Rev Neurobiol; 2016; 130():1-40. PubMed ID: 27678173 [TBL] [Abstract][Full Text] [Related]
17. Potential of Nanotechnology-based Formulations in Combating Pulmonary Infectious Diseases: A Current Scenario. Patel M; Mazumder R; Mishra R; Kant Kaushik K Curr Pharm Des; 2022; 28(42):3413-3427. PubMed ID: 36397631 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management Siafaka PI; Mutlu G; Okur NÜ Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090 [TBL] [Abstract][Full Text] [Related]
19. Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier. Sguizzato M; Esposito E; Cortesi R Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361084 [TBL] [Abstract][Full Text] [Related]
20. Nanoparticles and their antimicrobial properties against pathogens including bacteria, fungi, parasites and viruses. Khezerlou A; Alizadeh-Sani M; Azizi-Lalabadi M; Ehsani A Microb Pathog; 2018 Oct; 123():505-526. PubMed ID: 30092260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]